Literature DB >> 35440923

Using Health Information Technology to Create Pathways for Hepatitis C Treatment and Cure in West Virginia.

Adam Baus, Andrea Calkins, Judith Feinberg, Kim McManaway, Susan Moser, Cecil Pollard, Richard Sutphin.   

Abstract

This case study describes use of health information technology for enhanced team-based care and care coordination between primary care providers and infectious disease specialists for curing and eventually eliminating hepatitis C in West Virginia. This program, the West Virginia Hepatitis Academic Mentoring Partnership, aims to improve outcomes of West Virginians with chronic hepatitis C infection by training and supporting primary care providers to screen, diagnose, evaluate, treat, cure, and follow patients in the community rather than referring them to distant specialists with long wait times. This initiative supports health equity by increasing access to quality care in severely under-resourced rural areas. Primary care providers engage with hepatitis C experts in a web-based training and mentoring process, combined with informatics training in use of a customized Research Electronic Data Capture (REDCAP) platform for secure data tracking and bidirectional communication. This use of an informatics platform available to all partners supports shared decision-making between primary care providers and specialists, fostering a primary care learning network for improved hepatitis C care in West Virginia.
Copyright © 2022 by the American Health Information Management Association.

Entities:  

Keywords:  REDCap; health information technology; hepatitis C; team-based care

Mesh:

Year:  2022        PMID: 35440923      PMCID: PMC9013224     

Source DB:  PubMed          Journal:  Perspect Health Inf Manag        ISSN: 1559-4122


  20 in total

1.  Informatics-Supported Diabetes Prevention Programming in West Virginia.

Authors:  Adam Baus; Samantha Shawley-Brzoska; Jessica Wright; Sheryn Carey; Erikah DeFrehn Berry; Sandra Burrell; Megan Ross; Cecil Pollard; Audrey Semel; Andrea Calkins; Divya Gadde; Traci Jarrett
Journal:  Perspect Health Inf Manag       Date:  2021-03-15

2.  Identifying patients with hypertension: a case for auditing electronic health record data.

Authors:  Adam Baus; Michael Hendryx; Cecil Pollard
Journal:  Perspect Health Inf Manag       Date:  2012-04-01

3.  Developing Methods of Repurposing Electronic Health Record Data for Identification of Older Adults at Risk of Unintentional Falls.

Authors:  Adam Baus; Keith Zullig; Dustin Long; Charles Mullett; Cecil Pollard; Henry Taylor; Jeffrey Coben
Journal:  Perspect Health Inf Manag       Date:  2016-04-01

4.  An Electronic Health Record Data-driven Model for Identifying Older Adults at Risk of Unintentional Falls.

Authors:  Adam Baus; Jeffrey Coben; Keith Zullig; Cecil Pollard; Charles Mullett; Henry Taylor; Jill Cochran; Traci Jarrett; Dustin Long
Journal:  Perspect Health Inf Manag       Date:  2017-10-01

5.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Authors:  Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

6.  Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations.

Authors:  Gigi A Moreno; Alice Wang; Yuri Sánchez González; Oliver Díaz Espinosa; Diana K Vania; Brian R Edlin; Ronald Brookmeyer
Journal:  Value Health       Date:  2017-02-23       Impact factor: 5.725

7.  Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study.

Authors:  Alain H Litwin; John Jost; Katherine Wagner; Moonseong Heo; Alison Karasz; Judith Feinberg; Arthur Y Kim; Paula J Lum; Shruti H Mehta; Lynn E Taylor; Judith I Tsui; Irene Pericot-Valverde; Kimberly Page
Journal:  Contemp Clin Trials       Date:  2019-10-24       Impact factor: 2.226

8.  Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis.

Authors:  Paul Y Kwo; Amy Puenpatom; Zuoyi Zhang; Siu L Hui; Andrea A Kelley; David Muschi
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

9.  Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid.

Authors:  Timothy T Pham; Shellie L Keast; Kevin C Farmer; David M Thompson; R Chris Rathbun; Nancy J Nesser; Bethany P Holderread; Grant H Skrepnek
Journal:  J Manag Care Spec Pharm       Date:  2018-07

10.  Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting.

Authors:  Arshia Alimohammadi; Julie Holeksa; Astou Thiam; David Truong; Brian Conway
Journal:  Open Forum Infect Dis       Date:  2018-05-23       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.